Related Experiment Video
Updated: Jul 19, 2026
07:35
A Non-invasive Way to Isolate and Phenotype Cells from the Conjunctiva
Published on: July 5, 2017
Allergic conjunctivitis: update on pathophysiology and prospects for future treatment
Santa Jeremy Ono1, Mark B Abelson
1Department of Immunology, University College London, Institutes of Ophthalmology and Child Health and Moorfields Eye Hospital, NHS Trust, United Kingdom. santa.ono@ucl.ac.uk
The Journal of Allergy and Clinical Immunology
|January 8, 2005
Summary
Allergic conjunctivitis, a group of ocular surface diseases, involves inflammation and discomfort. Current treatments have risks, driving a search for safer, more effective therapies targeting new biological pathways.
Area of Science:
- Ophthalmology
- Immunology
- Allergy
Background:
- Allergic conjunctivitis encompasses acute and chronic ocular surface diseases, often linked to type 1 hypersensitivity.
- Inflammation, typically mast cell-mediated, causes symptoms like itching, redness, and photophobia, potentially leading to tissue remodeling in chronic cases.
Purpose of the Study:
- To provide an updated overview of allergic conjunctivitis, including clinical presentations, classification rationale, and pathogenesis.
- To review recent advancements in preclinical and clinical therapies for allergic conjunctivitis.
Main Methods:
- Literature review and synthesis of current research on allergic conjunctivitis.
- Analysis of clinical symptoms, disease classification, pathogenesis, and therapeutic strategies.
Main Results:
- Allergic conjunctivitis presents acutely (seasonal, perennial) and chronically (vernal, atopic, giant papillary).
- Severe cases cause significant discomfort and ocular surface damage, with current corticosteroid treatments posing risks like cataracts and glaucoma.
- Ongoing research focuses on identifying novel biotargets for improved treatment efficacy and safety.
Conclusions:
- Effective and safe treatments for severe allergic conjunctivitis are lacking, necessitating the exploration of new therapeutic targets.
- Advances in understanding disease pathogenesis are paving the way for refined treatment strategies for allergic conjunctivitis.
Related Concept Videos
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:22Microbiome of the Eye
The human eye has a specialized microbiota that reflects its unique anatomical and immunological environment. This low-biomass microbial community predominantly colonizes the conjunctiva and eyelid margins, playing a vital role in ocular surface homeostasis and defense. Despite its proximity to the richly colonized facial skin, the ocular surface maintains a distinct microbial profile due to continuous mechanical and biochemical defense mechanisms.The conjunctival surface hosts fewer microbial...